Navigation Links
Genes involved in biofilms

The biologist Alejandro Toledo Arana has identified two new genes that operate as regulators in the formation process of the biofilm of Staphylococcus aureus, one of the bacteria most frequently involved in infections following medical implants, and has explained the functioning of a structural protein involved in this process. His research was the subject of a PhD thesis recently defended at the Institute of Agribiotechnology, a joint CSIC and Public University of Navarra centre, and is an advance in the race to identify action targets for the development of pharmaceutical drugs to combat these infections.

The PhD, entitled Identification and characterisation of new factors involved in the processes of formation of biofilm from Gram-positive bacteria.

Chronic infections

Biofilms are communities of microorganisms in a matrix that joins them together and to living or inert substrates, points out Alejandro Toledo. Although they are widely found in nature, and in many cases have beneficial effects, their study has been boosted on discovering their relation to chronic infections associated to medical implants such as those tissues involving infections of the middle ear, of the prostate gland, pneumonia in patients with cystic fibrosis, osteomyelitis, etc.

In the interior of the biofilm, bacteria present greater resistance to antibiotics, to the opsonisation by antibodies and to phagocytosis, which explains the chronic character of these infections, states the author of the PhD.

The aim of the PhD was the characterisation of the process of formation of the Staphylococcus aureus biofilm.

Regulating mechanisms unknown to date

The starting point for the research was the Bap protein (Biofilm associated protein). Bap, according to the thesis, presents a structural organisation similar to other surface proteins of unknown function in a number of species of bacteria such as: Esp de Entero coccus faecalis, mus20 of Pseudomonas putida, and sty2875 of Salmonella typhi.

Thus, taking into account the structural homology between Bap and Esp, it was decided to analyse for a possiblerelationship between the presence of the esp gene and the ability to produce biofilm by E. faecalis. The results showed that the presence of the esp gene was involved in the formation processes of these biofilms.

Two new genes

The results obtained to date intuitively suggest the existence of various mechanisms for forming biofilm as a function of the origin of the bacteria strains, as a consequence of which it was decided to widen the scope of the research, using a strain of Staphylococcus aureus from otitis media.

For the identification of the genes involved in the formation of the biofilm of this strain, two different strategies were followed. The first, following the usual methods, involved identifying mutants that had lost the capacity to form biofilm, thus enabling identification of the essential genes and positive regulators of the process. The results showed that a positive regulator known as Pnp (Polynucleotide phosphorylase) exists and which regulates the accumulation of the main exopolysaccharide involved in the formation of the biofilm for this bacteria.

Moreover, the second strategy arose during the development of a medium chemically defined in order to study how environmental signals affect the process of formation of the biofilm. Unexpectedly, most of the clinical strains of Staphylococcus aureus were unable to form biofilm in the synthetic medium, which suggested to us that the process was, perhaps, repressed in this medium.


'"/>

Source:Elhuyar Fundazioa


Related biology news :

1. Genes In The Interferon System Important In Systemic Lupus Erythematosus
2. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
3. VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain
4. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
5. Where Bacteria Get Their Genes
6. Genes linked to treatment resistance in children with leukemia
7. Noise And Delays Explain Why Some Genes Oscillate In Activity
8. Genes involved in cell growth and cell division identified
9. Genes affecting blood pressure change as children become adults
10. Genes discovered that allow gum disease bacterium to invade arteries
11. Genes and genius: Researchers confirm association between gene and intelligence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... According to the new market research report "Biometric System Market by Authentication ... (Hardware and Software), Function (Contact and Non-contact), Application, and Region - Global ... from USD 10.74 Billion in 2015 to reach USD 32.73 Billion by ... Continue Reading ... ...
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/4/2016)... and CAMBRIDGE, Mass. ... , Dec. 4, 2016 SystemOne, a ... diagnostics software platforms for the developing world, and ... Care.™" a reality with its portable and ultrasensitive ... into a development and license agreement to integrate ...
(Date:12/2/2016)... 2, 2016 Amgen (NASDAQ: AMGN ) ... the submission of a Marketing Authorization Application (MAA) to the ... to Avastin ® (bevacizumab). The companies believe this submission ... "The submission of ABP 215 to the ... our oncology portfolio," said Sean E. Harper , M.D., ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic subtyping ... Using molecular test results from tumors with previously documented positive, negative, and ...
Breaking Biology Technology: